Recurrent Pericarditis: New Paradigm Shift in Diagnosis and Management

Agenda

• Moderator Introduction: Allan Klein, MD
• Case Presentation: Tom Kai Ming Wang, MBChB, MD
• Pathophysiology of Recurrent Pericarditis: Paul Cremer, MD
• Clinical Presentation (Prevalence & ESC Definitions): Christine Jellis, MD, PhD
• Role of Imaging Guided Therapy: Deborah Kwon, MD
• Clinical-Path Correlation: E. Rene Rodriguez, MD
• New Therapeutics: Role of Interleukin 1 Receptor Blockers: Allan Klein, MD
• Radical Pericardiectomy & Preliminary Data on Surgical Therapy: Pericardial Diseases Center

Learning Objectives:

• Describe the pathophysiology and diagnosis of pericarditis and appropriate treatment considerations.
• Discuss new therapies, such as IL-1 blockers, for patients with recurrent/refractory pericarditis.
• Recognize how a center of excellence works collaboratively to evaluate and manage acute pericarditis.

Complete CME process to claim your credit

Target Audience

This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.

Accreditation Statement

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic. In no event will The Cleveland Clinic be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.

The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Christine Jellis, MD, Deborah H Kwon, MD, Paul Cremer, MD, Tom K. Wang, MBChB, E. Rene Rodriguez, MD, Kathleen Breznai.

The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD: Cook Medical - Teaching and Speaking. Cryolife, Inc. - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Medtronic - Consulting. Edwards Lifesciences - Teaching and Speaking. Abbott - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Douglas Johnston, MD: Cryolife, Inc. - Advisor or review panel participant. Terumo - Teaching and Speaking. Edwards Lifesciences - Consulting. Allan Klein, MD: Pfizer - Consulting, Advisor or review panel participant. Elsevier - Intellectual property rights (Royalties or patent sales). Wolters-Kluwer - Intellectual property rights (Royalties or patent sales). Kiniksa Pharmaceuticals - Consulting, Research / Independent Contractor, Advisor or review panel participant, Principal or Co-Investigator of funded research. Cardiol Therapeutics Inc - Advisor or review panel participant.

For further information about this activity, contact Katie Breznai at breznak@ccf.org